Clinical Trials on Hematological Malignancies in Australia
Total 981 results
-
Melbourne HealthActive, not recruitingHaematological MalignancyAustralia
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
Antengene Therapeutics LimitedBristol-Myers SquibbRecruitingSolid Tumor | Hematological MalignancyAustralia
-
Bayside HealthThe Alfred; The Leukaemia Foundation of VictoriaUnknownRCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMTHematological MalignanciesAustralia
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
Antengene Discovery LimitedRecruitingAdvanced Solid Tumors | Hematological MalignanciesAustralia
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
Hutchison Medipharma LimitedIqvia Pty LtdUnknownHematologic MalignanciesAustralia
-
Monash UniversityRecruitingHypogammaglobulinemia | Haematological MalignancyAustralia
-
AstraZenecaTerminatedStudy of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological MalignanciesHaematological MalignanciesFrance, Italy, United States, Korea, Republic of, Germany, Australia
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, Japan, Taiwan, Australia, Germany, China
-
Melbourne HealthPeter MacCallum Cancer Centre, Australia; Western Sydney Local Health District and other collaboratorsEnrolling by invitationCytomegalovirus Infections | Immune Suppression | Haematological Malignancy | Organ or Tissue Transplant; ComplicationsAustralia
-
Robert Krause, MDCompletedInvasive Fungal Infection | Hematological Malignancy | Receipt of Solid Organ TransplantAustria
-
Atridia Pty Ltd.CompletedSolid Tumors and Hematologic MalignancyAustralia
-
Elisabethinen HospitalPfizerTerminated
-
Ascentage Pharma Group Inc.RecruitingHematologic MalignanciesUnited States, Australia
-
Curon Biopharmaceutical (Australia) Co Pty LtdNovotech (Australia) Pty LimitedTerminatedRelapsed Lymphoid Malignancies | Refractory Lymphoid MalignanciesAustralia
-
AbbVieGenentech, Inc.Active, not recruitingNon-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid MalignanciesUnited States, Australia
-
Medical University of ViennaCompleted
-
AbbVieRecruitingHematologic MalignanciesUnited States, Australia
-
BeiGeneCompletedB-cell MalignanciesAustralia
-
Clover Biopharmaceuticals AUS Pty LtdCompletedPeritoneal MalignanciesAustralia
-
AccentureCompletedHematologic MalignanciesKorea, Republic of, Australia, Canada
-
Medical University of ViennaRoche Pharma AG; Allcyte GmbHRecruitingRefractory Acute Myeloid Leukemia | Advanced Lymphoma | Refractory Lymphoma | Refractory Leukemia | Refractory T-Cell LymphomaAustria
-
Novartis PharmaceuticalsCompletedLymphoma | Leukemia | Multiple MyelomaUnited States, Germany, Australia
-
Heidelberg UniversityCompleted
-
Eucure (Beijing) Biopharma Co., LtdCompletedAdvanced Solid MalignanciesAustralia
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced MalignanciesAustralia, China
-
Humanigen, Inc.SuspendedMyelodysplastic Syndrome (MDS) | Myelofibrosis (MF)United States, Australia
-
GlaxoSmithKlineCompletedNeoplasmsSpain, United States, Korea, Republic of, United Kingdom, Australia
-
Centre Hospitalier Universitaire VaudoisUnknownHematologic Diseases | Hematologic Malignancy | Invasive Mold Infections | Breakthrough Invasive Mold InfectionsSwitzerland, Austria, Germany
-
Gilead SciencesCompletedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingSolid Tumors | Hematologic MalignanciesUnited States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
-
BeiGeneCompletedB-cell MalignanciesUnited States, Korea, Republic of, Australia, New Zealand, United Kingdom, Italy
-
Haisco Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory B-Cell MalignanciesChina, Australia
-
BeiGeneRecruitingMature B-Cell MalignanciesUnited States, Italy, Australia, New Zealand, Spain, Germany, United Kingdom
-
BeiGeneCompletedB-cell Lymphoid MalignanciesAustralia, Korea, Republic of, United States
-
Regeneron PharmaceuticalsSanofiCompletedMalignanciesUnited States, Korea, Republic of, Australia, Ireland, United Kingdom
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingSolid Malignancies or LymphomasAustralia
-
AbbVieGenentech, Inc.; AmgenTerminatedAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States, Australia, Germany
-
CSL LimitedCompletedIdiopathic Thrombocytopenic Purpura (ITP)Australia
-
Merck Sharp & Dohme LLCRecruitingLymphoma, B-Cell | Lymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States, Australia, Canada, Germany, Israel, Italy
-
The Hospital for Sick ChildrenBristol-Myers SquibbTerminatedRefractory or Recurrent Hypermutated Malignancies | Biallelic Mismatch Repair Deficiency (bMMRD) Positive PatientsUnited States, France, Canada, Australia, Israel
-
Novartis PharmaceuticalsRecruitingALK Positive MalignanciesGermany, France, Australia, Belgium, Italy, Korea, Republic of, Poland, China, United States, Taiwan, Brazil, Bulgaria, Hong Kong, Japan, Lebanon, Malaysia, Spain, Russian Federation, Colombia, Singapore, Czechia
-
University of SydneyUniversity of Roma La Sapienza; Australasian Bone Marrow Transplant Recipient... and other collaboratorsRecruiting
-
AmgenTerminatedAcute Myeloid Leukemia | Multiple Myeloma | AML | Myelodysplastic Syndrome | MDS | Non-Hodgkins Lymphoma | NHLUnited States, Australia, Italy, France, Greece, Japan
-
PfizerHospira, now a wholly owned subsidiary of PfizerCompleted
-
Novartis PharmaceuticalsActive, not recruitingAdvanced Malignancies That Harbor IDHR132 MutationsBelgium, Germany, Spain, Canada, Australia, United States, Netherlands, Singapore
-
Novartis PharmaceuticalsTerminatedPhilidelphia Positive Chronic Myeloid LeukaemiaAustralia
-
Bayside HealthNational Health and Medical Research Council, Australia; Monash UniversityRecruiting